The anti-inflammatory capacity of p38 is further demonstrated in mouse models of pneumococcal pneumonia and tuberculosis where its inhibition results in impaired bacterial clearance and increased TNF-α production both in vitro and in vivo[87]. Here, TNF is linked to pneumococcal pneumonia.